Physician

Nihar Kiritkumar Patel, M.D.

According to 2025 Medicare claims, Nihar Patel, M.D. (NPI: 1528228921) practices hematology/oncology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Williamson, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78681-4019.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 610 traditional Medicare patients, billed 180,430 HCPCS/CPT codes, and received $2,938,971 in Medicare payments. The top billing code was 96365 (Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less). Part D data shows 795 prescription claims across 164 beneficiaries totaling $1,154,001 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 20 claims. Open Payments data shows 26 records totaling $18,579. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $19,182 to $2,938,971. In contrast, Part D prescription costs have fallen sharply in recent years, from $9,196 to $1,154,001. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	114	259	$19,182
2016	457	2,031	$180,652
2017	586	2,484	$230,341
2018	523	2,408	$214,684
2019	514	2,258	$204,731
2020	474	2,060	$183,853
2021	466	1,912	$182,455
2022	575	60,188	$747,395
2023	590	172,704	$2,486,857
2024	610	180,430	$2,938,971

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	117	$9,196
2016	81	389	$219,081
2017	146	874	$1,409,837
2018	183	1,062	$3,291,334
2019	183	1,361	$4,495,475
2020	200	1,549	$5,502,798
2021	221	1,543	$5,434,866
2022	216	1,043	$3,825,492
2023	149	614	$422,645
2024	164	795	$1,154,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	27	$735
2019	N/R	13	$176
2020	N/R	20	$347
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	131	261	$46
96375	Injection of additional new drug or substance into vein	133	447	$11
80053	Blood test, comprehensive group of blood chemicals	168	612	$10
36415	Insertion of needle into vein for collection of blood sample	196	588	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	194	677	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	32	805	$517,022
Eliquis	Apixaban	103	3,785	$68,247
Xarelto	Rivaroxaban	34	1,586	$29,467
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	806	$983
Letrozole	Letrozole	50	2,984	$745

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$18,579	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nihar Kiritkumar Patel, M.D.?

Tedicare shows public-source Medicare data for Nihar Kiritkumar Patel, M.D. (NPI 1528228921), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nihar Kiritkumar Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nihar Kiritkumar Patel, M.D.?

Nihar Kiritkumar Patel, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Nihar Kiritkumar Patel, M.D. have Open Payments data?

Nihar Kiritkumar Patel, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.